(Q48685670)

14 February 2018

title

Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat. (English)

1 reference

14 February 2018

1 reference

1 reference

Smith SA

1

1 reference

14 February 2018

Lister CA

series ordinal

2

1 reference

14 February 2018

Toseland CD

series ordinal

3

1 reference

14 February 2018

Buckingham RE

series ordinal

4

1 reference

14 February 2018

publication date

1 December 2000

1 reference

14 February 2018

Diabetes, Obesity and Metabolism

published in

1 reference

14 February 2018

volume

2

1 reference

14 February 2018

issue

6

1 reference

14 February 2018

page(s)

363-372

1 reference

14 February 2018

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Insulin resistance and the prevention of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Role of nitric oxide in obesity-induced beta cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Induction of uncoupling protein-2 mRNA by troglitazone in the pancreatic islets of Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Substitution of pyridoxal 5'-phosphate in the O-acetylserine sulfhydrylase from Salmonella typhimurium by cofactor analogs provides a test of the mechanism proposed for formation of the alpha-aminoacrylate intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: a potential new insulin-sensitizing mechanism for thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00099.X

10.1046/J.1463-1326.2000.00099.X

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018